Asia Pacific Tissue Engineering Market Forecast to 2027

Asia Pacific Tissue Engineering Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Material Type (Biologically Derived Material, Synthetic Material, and Others), Applications (Orthopedic, Musculoskeletal and Spine, Skin, Cardiology and Vascular, Neurology, and Others), and Country

Report Code : TIPRE00013294 | Region : Asia Pacific | Industry : Biotechnology | Published Date : 28/Sep/2022

The tissue engineering market in Asia Pacific is expected to grow from US$2,177.47 million in 2022 to US$5,052.49 million by 2028. It is estimated to grow at a CAGR of 12.8% from 2022 to 2028.

Tissue engineering and regenerative medicine (TERM) have been proposed and developed for more than 30 years. Although several successful attempts at tissue regeneration have been made, TERM is still in its infancy. There are many unanswered fundamental questions regarding the selection of cell sources, development of tissue-specific materials, specialized bioreactors, and the construction of complex organs. After all, most therapies or treatments aim to enhance tissue regeneration, and stem cell engineering has opened a new avenue in regenerative medicine. Tissue engineering can be applied to construct various tissues, including blood vessels, nerve tissues, skin, and bones. Several techniques involving new materials, new structures, and novel surface modifications of biomaterials are developed for stem cell engineering. Also, a deep understanding of the interactions between cells and biomaterials is needed. Advances in tissue engineering research and its methodology led to the formation of scaffolds for bioprinters and then to the decellularized organs. More research into processes is overcoming the shortcomings of previous methods. Improving knowledge in the biology of regeneration, development in microelectronics, and 3D printing technology helps overcome the hurdles. In additing, cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis’s Kymriah was the first cell therapy solution offered for the treatment of B-cell acute leukemia, which opened opportunities for the emerging treatment therapy. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in pipeline, with three products—RCH-01, RCS-01, and RCT-01—in the development phase. Further, Sernova is engaged in the development of regenerative medicine technologies and has a huge pipeline of the products for various conditions, including diabetes, Hemophilia A, and hyperthyroidism. Therefore, rapid advancements in the development of regenerative medicines to provide effective solutions for chronic conditions are driving the growth of the market.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific tissue engineering market at a substantial CAGR during the forecast period.

Asia Pacific Tissue Engineering Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Tissue Engineering Market Segmentation

The Asia Pacific tissue engineering market is segmented on the basis of material type, application, and country. Based on material type, the market is segmented into biologically derived materials, synthetic materials, and others. In 2022, the biologically derived materials segment held the largest market share. However, the synthetic materials segment is expected to register the highest CAGR during the forecast period. Based on application, the market is segmented into orthopedic, musculoskeletal & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi & gynecology, urology, and others. In 2022, the orthopedic, musculoskeletal, & spine segment held the largest market share. However, the skin & integumentary segment is expected to register the highest CAGR in the market during the forecast period. Based on country, the Asia Pacific tissue engineering market is segmented into Japan, China, India, South Korea, Australia, and Rest of APAC. In 2022, Japan held the largest market share; and China is also expected to grow at the fastest CAGR during the forecast period.

Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Organogenesis Inc.; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. are among the leading companies in the Asia Pacific tissue engineering market.

At 12.8% CAGR, the Asia Pacific Tissue Engineering Market is speculated to be worth US$ 5,052.49 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Asia Pacific tissue engineering market was valued at US$ 2,177.47 million in 2022 and is expected to reach US$ 5,052.49 million by 2028, registering an annual growth rate of 12.8% from 2022 to 2028. Higher growth in the healthcare market across the region and elevating incidence of chronic diseases and broadening advancements in regenerative medicine.

The rising incidences of chronic illnesses, escalation in geriatric population, and increase in need for pediatric care are a few of the primary factors boosting the growth of the healthcare sector. The healthcare sector has been experiencing rapid transformation since the last couple of years. Various countries around the region favor the use of advanced technologies in healthcare. With an increase in the need for better healthcare facilities, technology-enabled care (TEC) solutions are in demand in the healthcare systems, especially in the emerging economies. As a result, various healthcare players have been investing significant amounts of their revenues in R&D activities to develop advanced solutions, including stem cell products, and associated therapeutic technologies. Also, the reimbursement provided for various medical procedures are likely to fuel the growth of this sector during the forecast period. The abovementioned factors are expected to generate growth opportunities for the tissue engineering market players during the forecast period.

On the contrary, excessive cost of treatment options involving tissue engineering.

Based on material type, the Asia Pacific tissue engineering market is segment into biologically derived materials, synthetic materials, and others. The biologically derived materials segment held 52.5% market share in 2022, amassing US$ 1,143.57 million. It is projected to garner US$ 2,670.32 million by 2028 to expand at 12.9% CAGR during 2022–2028.

Based on application, the Asia Pacific tissue engineering market is segmented into orthopedic, musculoskeletal, & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi, gynecology, urology, and others. The orthopedic, musculoskeletal, & spine segment held 34.4% market share in 2022, amassing US$ 748.52 million. It is projected to garner US$ 1,746.30 million by 2028 to expand at 12.9% CAGR during 2022–2028.

Based on country, the Asia Pacific tissue engineering market has been segmented into Japan, China, India, South Korea, Australia, and Rest of APAC. Our regional analysis states that Japan captured 26.6% market share in 2022. It was assessed at US 578.51 million in 2022 and is likely to hit US$ 1,384.26 million by 2028, exhibiting a CAGR of 13.3% during the forecast period.

Key players dominating the Asia Pacific tissue engineering market are Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Organogenesis Inc.; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. among others.

In July 2021 for PriMatrix Dermal Repair Scaffold to manage hard-to-heal diabetic foot ulcers (DFUs). In April 2018, Medtronic plc announced it has received FDA approval of Infuse Bone Graft for new spine surgery indications.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Tissue Engineering Market – By Material Type

1.3.2 Asia Pacific Tissue Engineering Market – By Application

1.3.3 Asia Pacific Tissue Engineering Market – By Country

2. Asia Pacific Tissue Engineering Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Tissue Engineering – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinion

5. Asia Pacific Tissue Engineering Market – Industry Dynamics

5.1 Key Drivers

5.1.1 Boosting Number of Road Accidents and Trauma Injuries, and Elevating Incidence of Chronic Diseases

5.1.2 Surging Technological Advancements in the Field of 3D Tissue Engineering

5.2 Key Market Restraints

5.2.1 Excessive Cost of Treatment Options Involving Tissue Engineering

5.3 Key Market Opportunities

5.3.1 Higher Growth in the Healthcare Market Across the Region

5.4 Future Trends

5.4.1 Broadening Advancements in Regenerative Medicine

5.5 Impact Analysis

6. Asia Pacific Tissue Engineering Market Analysis

6.1 Asia Pacific Tissue Engineering Market Revenue Forecast and Analysis

7. Asia Pacific Tissue Engineering Market Analysis – By Material Type

7.1 Overview

7.2 Asia Pacific Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)

7.3 Synthetic Material

7.3.1 Overview

7.3.2 Synthetic Material: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Biologically Derived Materials

7.4.1 Overview

7.4.2 Biologically Derived Materials: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Tissue Engineering Market – By Application

8.1 Overview

8.2 Asia Pacific Tissue Engineering Market, by Application, 2022 and 2028 (%)

8.3 Orthopedic, Musculoskeletal & Spine

8.3.1 Overview

8.3.2 Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Neurology

8.4.1 Overview

8.4.2 Neurology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Cardiology & Vascular

8.5.1 Overview

8.5.2 Cardiology & Vascular: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Skin & Integumentary

8.6.1 Overview

8.6.2 Skin & Integumentary: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Cancer

8.7.1 Overview

8.7.2 Cancer: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.8 GI & Gynaecology

8.8.1 Overview

8.8.2 GI & Gynaecology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.9 Urology

8.9.1 Overview

8.9.2 Urology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.10 Others

8.10.1 Overview

8.10.2 Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Tissue Engineering Market – Country Analysis

9.1 Overview

9.1.1 Asia Pacific: Tissue Engineering Market, by Country, 2022 & 2028 (%)

9.1.1.1 China: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1 China: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.2 China Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.3 China Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2 Japan: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Japan: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.2 Japan Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.3 Japan Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3 India: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1 India: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.2 India Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.3 India Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4 South Korea: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1 South Korea: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.2 South Korea Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.3 South Korea Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5 Australia: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.1 Australia: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.2 Australia Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.3 Australia Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6 Rest of Asia Pacific: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.1 Rest of Asia Pacific: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.2 Rest of Asia Pacific Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.3 Rest of Asia Pacific Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Tissue Engineering Market – Industry Landscape

10.1 Organic Developments

10.1.1 Overview

10.2 Inorganic Developments

10.2.1 Overview

11. Company Profiles

11.1 Zimmer Biomet

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 B. Braun Melsungen AG

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Stryker Corporation

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 AbbVie, Inc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Integra LifeSciences Holdings Corporation

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Organogenesis Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Medtronic

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Baxter International Inc.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Johnson and Johnson Services, Inc.

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 3M

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

11.11 Cook Biotech Inc.

11.11.1 Key Facts

11.11.2 Business Description

11.11.3 Products and Services

11.11.4 Financial Overview

11.11.5 SWOT Analysis

11.11.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES.

Table 1.             China Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             China Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Japan Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Japan Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5.             India Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             India Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 7.             South Korea Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             South Korea Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Australia Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Australia Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Rest of Asia Pacific Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Rest of Asia Pacific Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Organic Developments Done By Companies

Table 14.          Inorganic Developments Done By Companies

Table 15.          Glossary of Terms, Asia Pacific Tissue Engineering market

LIST OF FIGURES.

Figure 1.           Asia Pacific Tissue Engineering Market Segmentation

Figure 2.           Asia Pacific Tissue Engineering Segmentation - By Country

Figure 3.           Asia Pacific Tissue Engineering Market Overview

Figure 4.           The Biologically Derived Materials Segment Held Largest Share Of Material Type Segment In Tissue Engineering Market

Figure 5.           Japan Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Asia Pacific Tissue Engineering Market, Industry Landscape

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           Asia Pacific Tissue Engineering Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Asia Pacific Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)

Figure 10.        Synthetic Material: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Biologically Derived Materials: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Asia Pacific Tissue Engineering Market, by Application, 2022 and 2028 (%)

Figure 14.        Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Neurology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Cardiology & Vascular: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Skin & Integumentary: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        GI & Gynecology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Urology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Asia Pacific: Tissue Engineering Market, by Key Country – Revenue (2022) (US$ Million)

Figure 23.        Asia Pacific: Tissue Engineering Market, by Country, 2022 & 2028 (%)

Figure 24.        China: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Japan: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        India: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        South Korea: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Australia: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Rest of Asia Pacific: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - Asia Pacific Tissue Engineering Market

● Zimmer Biomet

● B. Braun Melsungen AG

● Stryker Corporation

● AbbVie, Inc.

● Integra LifeSciences Holdings Corporation      

● Organogenesis Inc.                                                    

● Medtronic

● Baxter International Inc.

● Johnson and Johnson Services, Inc.

● 3M

● Cook Biotech Inc.

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific tissue engineering market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific tissue engineering market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the tissue engineering market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP